Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis.

A D Jonasdottir Aleksandra Antovic Abdul Rashid Qureshi Annica Nordin Vivianne Malmström Iva Gunnarsson Annette Bruchfeld

Published in: Scandinavian journal of rheumatology (2022)

Plasma and urinary PTX3 seem to reflect disease activity in AAV better than the commonly used CRP. PTX3 may have a potential role as a biomarker in monitoring disease activity in AAV patients, particularly in patients with kidney involvement.

Keyphrases

disease activity
systemic lupus erythematosus
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
gene therapy
patient reported outcomes